Delivery Order SPE2DH25D0001-SPE2D425F335C
- Not listed
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order contract on August 12, 2025, by the Medical Supply Chain, a defense-focused federal agency, for CG8+ Cartridge products. The contract carries a ceiling value of $2,743.75 and is structured as a fixed-price delivery order with economic price adjustment provisions. The performance location is identified as North Chicago, Illinois, which aligns with Abbott's corporate headquarters and reflects the...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $4,167.00 by the Defense-affiliated Medical Supply Chain agency on August 18, 2025, with an ultimate completion date of August 20, 2025. The contract is for CG8+ cartridges and employs fixed-price pricing with economic price adjustment terms. The work will be performed in North Chicago, Illinois, the location of Abbott's headquarters. This delivery order was awarded without a set-aside...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,041.75 by the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of September 12, 2025. The contract covers CG8+ cartridge products and is structured as a fixed-price delivery order with economic price adjustment provisions. The award was made on September 10, 2025, with no set-aside designation, indicating full and open competition. Performance...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,736.25 by the Defense Medical Supply Chain on October 14, 2025, for CG8+ cartridges. The contract is structured as a fixed-price agreement with economic price adjustment provisions and does not utilize any set-aside designation, indicating full and open competition. Performance is scheduled for completion by October 16, 2025, at Abbott's facility in North Chicago, Illinois. This...
- Abbott Laboratories Inc., through its Abbott Point of Care division, has been awarded a delivery order valued at $2,173.14 by the Medical Supply Chain agency (a Defense component) on September 10, 2025, with a completion date of September 12, 2025. The contract covers CG8+ cartridges and is structured as a fixed-price delivery order with economic price adjustment provisions. The work will be performed in North Chicago, Illinois, where Abbott maintains its headquarters. This award represents a...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $2,247.84 on September 4, 2025, by the Medical Supply Chain, a defense-focused federal agency. The contract, designated as a Fixed Price with Economic Price Adjustment delivery order, calls for the supply of CG8+ cartridges to support federal healthcare operations. The work will be performed in North Chicago, Illinois, with an ultimate completion date of September 8, 2025. This award was...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $8,490.75 on September 15, 2025, by the Defense-focused Medical Supply Chain agency. The contract, designated as a fixed-price agreement with economic price adjustment provisions, calls for the delivery of CG8+ cartridges to support federal healthcare operations. The work will be performed at Abbott's North Chicago, Illinois facility, with an ultimate completion date of September 17, 2025....
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $4,451.76 on October 24, 2025, by the Defense Logistics Agency Medical Supply Chain. The contract, designated as CG8+ Cartridge with a fixed-price structure including economic price adjustment provisions, has an ultimate completion date of October 28, 2025. Performance will be conducted at Abbott's facility in North Chicago, Illinois. No small business set-aside was utilized for this...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,736.25 by the Defense-affiliated Medical Supply Chain agency on August 25, 2025. The contract, which does not include a set-aside designation, covers the supply of CG8+ cartridges and is classified as a fixed-price delivery order with economic price adjustment provisions. Performance will be completed by August 27, 2025, at Abbott's North Chicago, Illinois facility. This delivery...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order contract on September 26, 2025, by the Defense-focused Medical Supply Chain agency for the supply of CG8+ cartridges. This fixed-price contract with economic price adjustment carries a ceiling value of $1,237.50 and is scheduled for completion by September 30, 2025. The contract will be performed at Abbott's facility in North Chicago, Illinois, and was awarded through full and open competition...
- SPE2DH25D0001Indefinite Delivery Contract
- SPE2DH25D0001-SPE2D425F335CDelivery Order
Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order contract by the Medical Supply Chain (Defense) agency on June 24, 2025, for CG8+ cartridges. The contract is valued at $1,389.00 and carries a fixed-price structure with economic price adjustment provisions. Work will be performed in North Chicago, Illinois. This delivery order was awarded without set-aside designation, indicating full and open competition among qualified vendors. This delivery order represents a continuation of Abbott's significant role in supporting federal healthcare procurement, particularly through its existing Blanket Purchase Agreement vehicles with the Department of Veterans Affairs and other defense logistics channels. Abbott Laboratories Inc. has demonstrated substantial expertise in providing point-of-care testing supplies and diagnostic products to federal agencies across multiple integrated service networks. The CG8+ cartridge delivery supports Abbott's broader product portfolio in clinical testing technologies and in-vitro diagnostics, which are critical components of federal medical supply chain operations. Completion of this delivery order is scheduled for June 26, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 6/24/25 |